tradingkey.logo
tradingkey.logo
Search

Merck & Co Inc

MRK
Add to Watchlist
120.810USD
-3.220-2.60%
Close 07/14, 16:00ETQuotes delayed by 15 min
298.96BMarket Cap
33.86P/E TTM

Merck & Co Inc

120.810
-3.220-2.60%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-2.60%

5 Days

-6.25%

1 Month

+1.48%

6 Months

+8.83%

Year to Date

+14.77%

1 Year

+44.39%

Key Figures
123.310Open
123.650High
9.93MVolume
33.86P/E TTM
12.64P/E Dynamic
3.320Dividend TTM
0.40%Turnover Ratio
124.030Prev. Close
120.160Low
584.47MTurnover
17.47P/E Static
5.68P/B
2.75%Div Yield TTM
7.33%ROA
125.14052wk High
1.28Volume Ratio
17.12BNet Profit
2.47BShares
3.5675EPS TTM
0.22Beta
18.97%ROE
75.40052wk Low
2.81%Amplitude
75.70%Gross Margin
298.96BMarket Cap
2.69Reward/Risk
1.56%Risk Rate

TradingKey Stock Score of Merck & Co Inc

Currency: USD Updated: 2026-07-13

Key Insights

Merck & Co Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 38 out of 156 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 131.67.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Merck & Co Inc's Score

Industry at a Glance

Industry Ranking
38 / 156
Overall Ranking
92 / 4569
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

42°C

Very Low
Very High
Neutral

Merck & Co Inc Highlights

StrengthsRisks
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 65.01B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 46.40%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 46.40%.
Fairly Valued
The company’s latest PE is 34.77, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.01B shares, decreasing 0.52% quarter-over-quarter.
Held by Bill Smead
Star Investor Bill Smead holds 2.47M shares of this stock.

Analyst Rating

Based on 32 analysts
Buy
Current Rating
131.666
Target Price
+6.58%
Upside Space

Earnings Forecast

Analyst Rating

Based on 32 analysts
Buy
Current Rating
131.666
Target Price
+6.58%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Merck & Co Inc
MRK
32
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
34
AbbVie Inc
ABBV
33
1
2
3
...
36

Indicators

Indicators
Sell(3)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-1.263
Neutral
RSI(14)
46.813
Neutral
STOCH(KDJ)(9,3,3)
14.277
Sell
ATR(14)
3.532
High Vlolatility
CCI(14)
-131.853
Sell
Williams %R
88.219
Oversold
TRIX(12,20)
0.312
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
123.882
Sell
MA10
125.848
Sell
MA20
122.852
Sell
MA50
118.717
Buy
MA100
118.223
Buy
MA200
108.779
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Merck & Co Inc Info

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
Ticker SymbolMRK
CompanyMerck & Co Inc
CEODavis (Robert M)
Websitehttps://www.merck.com/

Shareholders

Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
6.52%
BlackRock Institutional Trust Company, N.A.
5.51%
State Street Investment Management (US)
4.86%
Wellington Management Company, LLP
3.50%
Vanguard Portfolio Management, LLC
2.73%
Other
76.88%

FAQs

What is the current price of Merck & Co Inc (MRK)?

The current price of Merck & Co Inc (MRK) is 120.81.

What is the symbol of Merck & Co Inc?

The ticker symbol of Merck & Co Inc is MRK.

What is the 52-week high of Merck & Co Inc?

The 52-week high of Merck & Co Inc is 125.14.

What is the 52-week low of Merck & Co Inc?

The 52-week low of Merck & Co Inc is 75.40.

What is the market capitalization of Merck & Co Inc?

The market capitalization of Merck & Co Inc is 298.96B.

Is Merck & Co Inc (MRK) currently rated as Buy, Hold, or Sell?

According to analysts, Merck & Co Inc (MRK) has an overall rating of Buy, with a price target of 131.67.

What is the Earnings Per Share (EPS TTM) of Merck & Co Inc (MRK)?

The Earnings Per Share (EPS TTM) of Merck & Co Inc (MRK) is 7.30.
tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.